The novel coronavirus outbreak began in Wuhan, China, in Dec. 2019. Interestingly, Moderna, together with the National Institute of Allergy and Infectious Diseases (NIAID), sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill on Dec. 12 2019
